Your browser doesn't support javascript.
loading
Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States.
Pariser, Ashley C; Sedghi, Tannaz; Soulos, Pamela R; Killelea, Brigid; Gross, Cary P; Mougalian, Sarah S.
Afiliação
  • Pariser AC; Yale Cancer Center, Yale New Haven Hospital, 20 York Street, Ste North Pavilion 1, New Haven, CT, 06510, USA.
  • Sedghi T; Yale COPPER, Harkness Office Building, 367 Cedar Street, New Haven, CT, 06510, USA.
  • Soulos PR; Department of Internal Medicine, Yale University School of Medicine, 330 Cedar St, Boardman 110, P.O. Box 208056, New Haven, CT, 06520-805, USA.
  • Killelea B; Yale COPPER, Harkness Office Building, 367 Cedar Street, New Haven, CT, 06510, USA.
  • Gross CP; Department of Internal Medicine, Yale University School of Medicine, 330 Cedar St, Boardman 110, P.O. Box 208056, New Haven, CT, 06520-805, USA.
  • Mougalian SS; Department of Surgery, Yale University School of Medicine, P.O. Box 208062, New Haven, CT, 06520-8062, USA.
Breast Cancer Res Treat ; 178(2): 419-426, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31401686
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Hormonais Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Hormonais Idioma: En Ano de publicação: 2019 Tipo de documento: Article